Advancing Precision Dementia Care With Genetic-Exposome Risk Assessment | Synapse
April 8, 2026
Advancing Precision Dementia Care With Genetic-Exposome Risk Assessment
Key Points
The central aim is to present a framework for risk assessment that integrates genetic and environmental factors for Alzheimer disease.
Proposes an integrated genetic-exposome risk assessment framework.
Focuses on early identification strategies for Alzheimer disease.
Discusses targeted treatment approaches based on individualized risk profiles.
Advocates for enhanced accuracy in identifying individuals at risk for Alzheimer disease.
Proposes strategies for personalized treatment plans that address both genetic and environmental influences.
Abstract
This Viewpoint advocates for an integrated genetic-exposome risk assessment framework for early identification and targeted treatment of Alzheimer disease.